Recursion Pharmaceuticals, Inc.
RXRX
$3.05
-$0.10-3.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.95% | 12.65% | 25.66% | 4.93% | -15.80% |
| Total Receivables | -44.89% | 12.50% | 1.41% | -53.16% | -6.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -- | -- | -- | -91.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -10.26% | 2.48% | -19.99% | 15.23% | -14.71% |
| Total Current Assets | -12.71% | 13.83% | 21.62% | 0.52% | -18.22% |
|
|
|||||
| Total Current Assets | -12.71% | 13.83% | 21.62% | 0.52% | -18.22% |
| Net Property, Plant & Equipment | -7.17% | -6.49% | -6.38% | -5.46% | -12.19% |
| Long-term Investments | -1.23% | 0.07% | -1.36% | 3.89% | 6.21% |
| Goodwill | -1.23% | 0.07% | -1.36% | 3.89% | 6.21% |
| Total Other Intangibles | -5.11% | -3.86% | -5.56% | 1.65% | -0.02% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.75% | -0.31% | 32.66% | -35.58% | 9.90% |
| Total Assets | -9.13% | 5.33% | 7.46% | -0.22% | -9.90% |
|
|
|||||
| Total Accounts Payable | 12.31% | 30.02% | -27.85% | -23.01% | 16.07% |
| Total Accrued Expenses | -23.49% | -3.64% | -13.07% | 50.43% | -31.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.75% | 6.41% | -0.20% | 0.22% | -8.01% |
| Total Finance Division Other Current Liabilities | -11.76% | -21.13% | 17.81% | -0.13% | -34.85% |
| Total Other Current Liabilities | -11.76% | -21.13% | 17.81% | -0.13% | -34.85% |
| Total Current Liabilities | -12.19% | -4.77% | -5.44% | 15.53% | -24.27% |
|
|
|||||
| Total Current Liabilities | -12.19% | -4.77% | -5.44% | 15.53% | -24.27% |
| Long-Term Debt | 3,620.73% | -98.38% | -16.16% | -13.68% | 2,304.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -23.52% | 11.97% | -6.31% | -4.69% | -34.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.10% | 2.80% | -10.59% | -3.34% | 11.97% |
| Total Liabilities | -8.31% | -2.64% | -7.99% | 3.21% | -10.28% |
|
|
|||||
| Common Stock & APIC | 0.68% | 6.35% | 11.18% | 5.00% | 3.23% |
| Retained Earnings | -5.66% | -5.49% | -8.99% | -10.52% | -14.14% |
| Treasury Stock & Other | -27.39% | 7.70% | -21.84% | 208.38% | 285.22% |
| Total Common Equity | -9.38% | 8.02% | 13.90% | -1.58% | -9.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.38% | 8.02% | 13.90% | -1.58% | -9.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.38% | 8.02% | 13.90% | -1.58% | -9.74% |
|
|
|||||